Sinclair IS Pharma PLC (SPH.L)
17 May 2013
|Market Cap (Mil.):||£122.32|
|Shares Outstanding (Mil.):||434.91|
LONDON, Feb 12 - Sinclair IS Pharma PLC : * Licence and distribution agreement with menarini group in Italy, Spain and
LONDON, Feb 12 - Sinclair IS Pharma PLC : * H1 revenues of £23.0 million (H1 12: £23.4 million) * H1 adjusted loss before tax of £0.4 million (H1 12: loss of £0.6 million)
LONDON, Jan 10 - Sinclair IS Pharma PLC : * Revenues for the first half expected to be approximately £23.0 million, +4%
LONDON, Dec 19 - Sinclair IS Pharma PLC : * Sinclair and Biocodex sign 10-year partnership to commercialise portfolio in
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Sinclair IS Pharma PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.